StonvexLoading…
StonvexStonvexStonvexCore line items from RELY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.64B | $1.26B | $944.28M | $653.56M |
Operating Income | $77.47M | $-39.09M | $-114.19M | $-121.04M |
Net Income | $67.93M | $-36.98M | $-117.84M | $-114.02M |
EPS (Diluted) | $0.31 | $-0.19 | $-0.65 | $-0.68 |
Total Assets | $1.46B | $1.01B | $1.04B | $695.95M |
Total Liabilities | $589.92M | $347.40M | $506.97M | $215.87M |
Cash & Equivalents | $542.43M | $368.10M | $323.71M | $300.63M |
Free Cash Flow OCF − CapEx | $295.65M | $105.60M | $63.95M | $-112.33M |
Shares Outstanding | 210.63M | 200.53M | 188.44M | 173.25M |